Pharma Mar Overview

  • Founded
  • 1986

Founded
  • Status
  • Public

  • Employees
  • 477

Employees
  • Stock Symbol
  • PHM

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $67.41

  • (As of Thursday Closing)

Pharma Mar General Information

Description

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
MAD
Primary Office
  • Avenida De los Reyes, 1
  • Polígono Industrial La Mina
  • 28770 Colmenar Viejo
  • Spain
+34 918 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharma Mar Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$67.41 $68.14 $52.56 - $98.41 $1.21B 18M 63.2K $5.84

Pharma Mar Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 1,202,658 978,458 1,424,746 949,099
Revenue 269,183 271,729 307,732 96,070
EBITDA 121,703 122,622 177,376 (10,934)
Net Income 105,293 109,787 156,467 (12,738)
Total Assets 421,925 417,094 406,208 139,691
Total Debt 53,236 55,856 69,696 96,464
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharma Mar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharma Mar‘s full profile, request access.

Request a free trial

Pharma Mar Patents

Pharma Mar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3123744-A1 Anticancer compounds Pending 17-Dec-2018 0000000000
AU-2019400736-A1 Anticancer compounds Pending 17-Dec-2018 0000000000
EP-3898613-A1 Anticancer compounds Pending 17-Dec-2018 0000000000
CA-3117268-A1 Antibody drug conjugates comprising ecteinascidin derivatives Pending 25-Oct-2018 00000000000
AU-2019368687-A1 Antibody drug conjugates comprising ecteinascidin derivatives Pending 25-Oct-2018 A61K47/6803
To view Pharma Mar’s complete patent history, request access »

Pharma Mar Executive Team (8)

Name Title Board Seat Contact Info
José Sousa-Faro Ph.D Board Member & Chief Executive Officer
Maria de Francia Caballero Chief Financial Officer
Pascal Besman Chief Operating Officer
José Martinez-Losa Director, Capital Markets & Investor Relations
María Marín de la Plaza Capital Markets & Investor Relations
You’re viewing 5 of 8 executive team members. Get the full list »

Pharma Mar Board Members (3)

Name Representing Role Since
000 000 0000000000000 Self Board Member 000 0000
000é 00000-0000 00.0 Pharma Mar Board Member & Chief Executive Officer 000 0000
0000000000 0000000 Pharma Mar Board Member 000 0000
To view Pharma Mar’s complete board members history, request access »

Pharma Mar Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharma Mar Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharma Mar‘s full profile, request access.

Request a free trial

Pharma Mar Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 02-Nov-2014 0000000000 Biotechnology
To view Pharma Mar’s complete acquisitions history, request access »